Candriam Equities L Oncology Impact, N - Capitalisation/ LU2346866317 /
NAV2024-06-10 | Chg.+1.0100 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
159.3800EUR | +0.64% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV2024-06-10 | Chg.+1.0100 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
159.3800EUR | +0.64% | reinvestment | Equity Worldwide | Candriam ▶ |